![](https://cdn.koreabiomed.com/news/thumbnail/202407/24567_25508_4616_v150.jpg)
Mirogabalin emerges as promising treatment for chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a significant adverse effect that impacts the quality of life and treatment outcomes for cancer patients. As the population ages and cancer incidence rises, managing CIPN is becoming increasingly …